WEKO3
アイテム
{"_buckets": {"deposit": "b4550177-b2aa-4e67-b42a-dcd7f2fdce1a"}, "_deposit": {"created_by": 2, "id": "5322", "owners": [2], "pid": {"revision_id": 0, "type": "depid", "value": "5322"}, "status": "published"}, "_oai": {"id": "oai:nagasaki-u.repo.nii.ac.jp:00005322", "sets": ["9"]}, "author_link": ["22391", "22387", "22389", "22393", "22390", "22394", "22388", "22399", "22386", "22384", "22395", "22385", "22397", "22398", "22396", "22392"], "item_2_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2014-02-13", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "1", "bibliographicPageStart": "27", "bibliographicVolumeNumber": "14", "bibliographic_titles": [{"bibliographic_title": "BMC Gastroenterology"}]}]}, "item_2_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Background: Apoptosis inhibitor of macrophage (AIM) and adipocytokines are involved in the metabolic syndrome, which has been putatively associated with the progression of chronic hepatitis C (CHC). However, the association between these cytokines and CHC is not fully elucidated. The aim of this study is to test whether serum levels of AIM and adipocytokines are associated with histological features, homeostasis model assessment-insulin resistance index (HOMA-IR), or whole body insulin sensitivity index (WBISI) in CHC patients.Methods: Serum samples were obtained from 77 patients with biopsy-proven CHC. In 39 patients without overt diabetes mellitus, a 75 g oral glucose tolerance test (OGTT) was performed and HOMA-IR and WBISI were calculated.Results: A serum AIM level of ?1.2 μg/ml was independently associated with advanced hepatic fibrosis (F2 or F3) (odds ratio [OR], 5.612; 95% confidence interval [CI], 1.103-28.563; P = 0.038) based on a multivariate analysis, but there was no significant association between AIM and hepatic steatosis or inflammation. Furthermore, a serum leptin level of ?8.6 ng/ml was independently associated with the presence of hepatic steatosis (?5%) (OR, 6.195; 95% CI, 1.409-27.240; P = 0.016), but not hepatic fibrosis or inflammation. No relationship was observed between levels of adiponectin or resistin and hepatic histological parameters based on a multivariate analysis. Although serum levels of leptin, resistin, and adiponectin were significantly correlated with HOMA-IR and WBISI, there was no significant relationship between serum AIM levels and HOMA-IR or WBISI, respectively.Conclusion: High serum levels of AIM in CHC patients are potentially related to advanced hepatic fibrosis. AIM and adipocytokines are possibly associated with pathological changes via a different mechanism.", "subitem_description_type": "Abstract"}]}, "item_2_description_63": {"attribute_name": "引用", "attribute_value_mlt": [{"subitem_description": "BMC Gastroenterology, 14(1), 27; 2014", "subitem_description_type": "Other"}]}, "item_2_publisher_33": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "BioMed Central"}]}, "item_2_relation_12": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type": "isIdenticalTo", "subitem_relation_type_id": {"subitem_relation_type_id_text": "10.1186/1471-230X-14-27", "subitem_relation_type_select": "DOI"}}]}, "item_2_rights_13": {"attribute_name": "権利", "attribute_value_mlt": [{"subitem_rights": "c 2014 Mera et al.; licensee BioMed Central Ltd."}, {"subitem_rights": "This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated."}]}, "item_2_source_id_7": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "1471230X", "subitem_source_identifier_type": "ISSN"}]}, "item_2_version_type_16": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Mera, Kumiko"}], "nameIdentifiers": [{"nameIdentifier": "22384", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Uto, Hirofumi"}], "nameIdentifiers": [{"nameIdentifier": "22385", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Mawatari, Seiichi"}], "nameIdentifiers": [{"nameIdentifier": "22386", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ido, Akio"}], "nameIdentifiers": [{"nameIdentifier": "22387", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yoshimine, Yozo"}], "nameIdentifiers": [{"nameIdentifier": "22388", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nosaki, Tsuyoshi"}], "nameIdentifiers": [{"nameIdentifier": "22389", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Oda, Kohei"}], "nameIdentifiers": [{"nameIdentifier": "22390", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tabu, Kazuaki"}], "nameIdentifiers": [{"nameIdentifier": "22391", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kumagai, Kotaro"}], "nameIdentifiers": [{"nameIdentifier": "22392", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tamai, Tsutomu"}], "nameIdentifiers": [{"nameIdentifier": "22393", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Moriuchi, Akihiro"}], "nameIdentifiers": [{"nameIdentifier": "22394", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Oketani, Makoto"}], "nameIdentifiers": [{"nameIdentifier": "22395", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Shimada, Yuko"}], "nameIdentifiers": [{"nameIdentifier": "22396", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hidaka, Masaaki"}], "nameIdentifiers": [{"nameIdentifier": "22397", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Eguchi, Susumu"}], "nameIdentifiers": [{"nameIdentifier": "22398", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tsubouchi, Hirohito"}], "nameIdentifiers": [{"nameIdentifier": "22399", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2020-12-21"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "BMCGas14_27.pdf", "filesize": [{"value": "314.1 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 314100.0, "url": {"label": "BMCGas14_27.pdf", "url": "https://nagasaki-u.repo.nii.ac.jp/record/5322/files/BMCGas14_27.pdf"}, "version_id": "545a92d1-510a-4b66-ba93-9440782cdb46"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "Adipocytokine", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Apoptosis inhibitor of macrophage", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Chronic hepatitis", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Hepatic fibrosis", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Hepatitis C virus", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Insulin resistance", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Serum levels of apoptosis inhibitor of macrophage are associated with hepatic fibrosis in patients with chronic hepatitis C", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Serum levels of apoptosis inhibitor of macrophage are associated with hepatic fibrosis in patients with chronic hepatitis C"}]}, "item_type_id": "2", "owner": "2", "path": ["9"], "permalink_uri": "http://hdl.handle.net/10069/34387", "pubdate": {"attribute_name": "公開日", "attribute_value": "2014-05-16"}, "publish_date": "2014-05-16", "publish_status": "0", "recid": "5322", "relation": {}, "relation_version_is_last": true, "title": ["Serum levels of apoptosis inhibitor of macrophage are associated with hepatic fibrosis in patients with chronic hepatitis C"], "weko_shared_id": -1}
Serum levels of apoptosis inhibitor of macrophage are associated with hepatic fibrosis in patients with chronic hepatitis C
http://hdl.handle.net/10069/34387
http://hdl.handle.net/10069/343877c098e95-0655-41d9-8992-a0d90084cb3e
名前 / ファイル | ライセンス | アクション |
---|---|---|
BMCGas14_27.pdf (314.1 kB)
|
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2014-05-16 | |||||
タイトル | ||||||
タイトル | Serum levels of apoptosis inhibitor of macrophage are associated with hepatic fibrosis in patients with chronic hepatitis C | |||||
言語 | ||||||
言語 | eng | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Adipocytokine | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Apoptosis inhibitor of macrophage | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Chronic hepatitis | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Hepatic fibrosis | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Hepatitis C virus | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Insulin resistance | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
著者 |
Mera, Kumiko
× Mera, Kumiko× Uto, Hirofumi× Mawatari, Seiichi× Ido, Akio× Yoshimine, Yozo× Nosaki, Tsuyoshi× Oda, Kohei× Tabu, Kazuaki× Kumagai, Kotaro× Tamai, Tsutomu× Moriuchi, Akihiro× Oketani, Makoto× Shimada, Yuko× Hidaka, Masaaki× Eguchi, Susumu× Tsubouchi, Hirohito |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Background: Apoptosis inhibitor of macrophage (AIM) and adipocytokines are involved in the metabolic syndrome, which has been putatively associated with the progression of chronic hepatitis C (CHC). However, the association between these cytokines and CHC is not fully elucidated. The aim of this study is to test whether serum levels of AIM and adipocytokines are associated with histological features, homeostasis model assessment-insulin resistance index (HOMA-IR), or whole body insulin sensitivity index (WBISI) in CHC patients.Methods: Serum samples were obtained from 77 patients with biopsy-proven CHC. In 39 patients without overt diabetes mellitus, a 75 g oral glucose tolerance test (OGTT) was performed and HOMA-IR and WBISI were calculated.Results: A serum AIM level of ?1.2 μg/ml was independently associated with advanced hepatic fibrosis (F2 or F3) (odds ratio [OR], 5.612; 95% confidence interval [CI], 1.103-28.563; P = 0.038) based on a multivariate analysis, but there was no significant association between AIM and hepatic steatosis or inflammation. Furthermore, a serum leptin level of ?8.6 ng/ml was independently associated with the presence of hepatic steatosis (?5%) (OR, 6.195; 95% CI, 1.409-27.240; P = 0.016), but not hepatic fibrosis or inflammation. No relationship was observed between levels of adiponectin or resistin and hepatic histological parameters based on a multivariate analysis. Although serum levels of leptin, resistin, and adiponectin were significantly correlated with HOMA-IR and WBISI, there was no significant relationship between serum AIM levels and HOMA-IR or WBISI, respectively.Conclusion: High serum levels of AIM in CHC patients are potentially related to advanced hepatic fibrosis. AIM and adipocytokines are possibly associated with pathological changes via a different mechanism. | |||||
書誌情報 |
BMC Gastroenterology 巻 14, 号 1, p. 27, 発行日 2014-02-13 |
|||||
出版者 | ||||||
出版者 | BioMed Central | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 1471230X | |||||
DOI | ||||||
関連タイプ | isIdenticalTo | |||||
識別子タイプ | DOI | |||||
関連識別子 | 10.1186/1471-230X-14-27 | |||||
権利 | ||||||
権利情報 | c 2014 Mera et al.; licensee BioMed Central Ltd. | |||||
権利 | ||||||
権利情報 | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. | |||||
著者版フラグ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
引用 | ||||||
内容記述タイプ | Other | |||||
内容記述 | BMC Gastroenterology, 14(1), 27; 2014 |